Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0000950170-24-113263

President and CEO sold 3,607 shares at $0.88 ($3,172)

From the SEC's structured data for this filing

Trades in this filing

Paulson Richard A. · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-10-04 Sale : show line 1 in the form −3,607 $0.88 $3,172 1,135,607 D
Open-market sales · 3,607 sh · avg $0.88 · $3,172
Loading xslF345X05/ownership.xml…